Genmab A/S buy Lars
Start price
08.11.21
/
50%
€401.20
Target price
08.11.22
-
Performance (%)
-13.86%
End price
21.07.22
€345.60
Summary
This prediction ended on 21.07.22 with a price of €345.60. The price of Genmab A/S has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.86%. Lars has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Genmab A/S | 1.241% | 1.241% | 25.014% | -37.579% |
| iShares Core DAX® | 0.423% | 5.706% | 4.696% | 50.380% |
| iShares Nasdaq 100 | 4.096% | 16.639% | 38.946% | 104.416% |
| iShares Nikkei 225® | 4.469% | 18.343% | 50.386% | 74.972% |
| iShares S&P 500 | 1.788% | 9.644% | 26.896% | 72.280% |
Comments by Lars for this prediction
In the thread Genmab A/S diskutieren
Lars hat das Wertpapier Genmab A/S in seinem Wikifolio Wikifolio WF00074737 von Lars gekauft.